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Background
We have previously reported on levels of adherence to
HIV medications and psychosocial factors associated with
adherence in an outpatient HIV primary care clinic serving
disadvantaged, largely African American patients in West
Baltimore. In our most recent study of 70 outpatients,
missed doses were significantly correlated with depressive
symptoms, social instability, and the number of severity
of current life stressors, in concert with the literature. This
study found uniquely that patients' trust and confidence
in their medical providers were the strongest predictors of
better adherence. There are no studies, however, which
systematically evaluate adherence and associated factors
among hospitalized inpatients, a population that has
received insufficient attention.
Methods
Baseline psychosocial and clinical variables were assessed
for 90 inpatients and 78 outpatients. Almost none of the
inpatients could be classified as optimally adherent
(>95%), compared to the outpatients (>50% adherent
>95%). Although both populations reported a mean of 3+
depressive symptoms, the inpatients acknowledged more
severe psychiatric symptoms. Compared to outpatients,
HIV+ inpatients had lower CD4+ cell counts, were more
likely to have recently abused drugs, to cope by avoidance
and substance abuse, and to be homeless.
Conclusion
HIV+ inpatients suffer from multiple social and psycho-
logical co-morbidities that contribute to poor adherence.
To improve their prognoses, these problems must be
addressed.
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